Cv. Pardo et al., FE2-MEDIATED BINDING OF SEROTONIN AND DOPAMINE TO SKELETAL-MUSCLE ACTIN - RESEMBLANCE TO SEROTONIN BINDING-PROTEINS(), European journal of pharmacology. Molecular pharmacology section, 288(2), 1995, pp. 209-218
Fe2+ stimulates the binding of [H-3]serotonin and [H-3]dopamine to rab
bit skeletal muscle actin. This binding is inhibited by reducing agent
s (sodium ascorbate, vitamin E), by superoxide dismutase and by sulfhy
dryl group-modifying reagents (N-ethylmaleimide, 2,2'-dinitro-5,5'-dit
hiobenzoic acid). The effect of Fe2+ is mimicked by oxidants (sodium p
eriodate, potassium nitroso-disulfonate) and by superoxide radicals. O
nce formed, the binding cannot be decreased by a large excess of monoa
mine. It is proposed that Fe2+ catalyses the autoxidation of the monoa
mines by generating oxygen free radicals, and the oxidation products a
re likely to bind covalently to exposed cysteine residues of actin. Di
gestion of [H-3]dopamine-labelled actin by cyanogen bromide and then b
y V8 protease(EC3.4.21.19) yields two labelled peptides whose apparent
molecular weights (4.1 and 1.2 kDa) are compatible with the labelling
of cysteine-10 and -374. Fe2+ also inactivates some of the binding si
tes of actin. This inactivation, and the covalent nature of the bindin
g precludes the interpretation of monoamine saturation and competition
binding data in terms of reversible bimolecular interactions.